Adaptive Biotechnologies ADPT Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's non-controlling interests?
- Adaptive Biotechnologies (ADPT) reported non-controlling interests of $7.9M in Q1 2026.
- How has Adaptive Biotechnologies's non-controlling interests changed year-over-year?
- Adaptive Biotechnologies's non-controlling interests increased by 4011.4% year-over-year, from -$202K to $7.9M.
- What is the long-term trend for Adaptive Biotechnologies's non-controlling interests?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's non-controlling interests has grown at a 174.1% compound annual growth rate (CAGR), from $110K to $6.21M.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.